# Ogilvie Syndrome: A Therapeutic Challenge

**Authors:** Ana Sofia Reis, Ana Rita Antunes, Lígia R Santos

PMC · DOI: 10.7759/cureus.103754 · Cureus · 2026-02-17

## TL;DR

Ogilvie syndrome is a rare condition causing colonic dilation, and this paper presents a case to guide its management and improve medical education.

## Contribution

The paper provides a practical case study to address the lack of clear therapeutic guidelines for Ogilvie syndrome.

## Key findings

- Conservative measures are typically the first step in managing Ogilvie syndrome.
- Refractory cases may need endoscopic or pharmacologic interventions.
- The case presented supports better clinical decision-making and education.

## Abstract

Ogilvie syndrome, or acute colonic pseudo-obstruction, is a rare disorder characterized by colonic dilation without mechanical obstruction. It primarily affects elderly or hospitalized patients and can lead to serious complications, including ischemia and perforation. Management typically begins with conservative measures, but refractory cases may require endoscopic or pharmacologic interventions. Current literature lacks robust evidence to guide the optimal therapeutic approach. We present a case that demonstrates practical management strategies, mitigates therapeutic inertia, and supports continuous medical education.

## Full-text entities

- **Diseases:** colonic dilation (MESH:D003108), ischemia (MESH:D007511), Ogilvie Syndrome (MESH:D003112)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13000660/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13000660/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC13000660/full.md

---
Source: https://tomesphere.com/paper/PMC13000660